Unclaimed Scholar Profile
Are you Ian Sanne? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of the WitwatersrandASIDASID-8842-9531-5881 orcid.org/0000-0003-4921-5611
Ian Sanne
University of the Witwatersrand•South Africa
Faculty researcher at University of the Witwatersrand (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Policy & Economics Specialist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#HIV/AIDS Research and Interventions#HIV/AIDS drug development and treatment#HIV Research and Treatment#Tuberculosis Research and Epidemiology
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 21,017 | 10,088 |
| h-index | 65 | 49 |
| i10-index | 215 | 151 |
Annual Citation Growth
Verified Citations / Year0
20201.0k
2021+40%1.4k
2022+29%1.8k
2023+33%2.4k
2024-8%2.2k
2025-45%1.2k
2026Scholarship Distribution & Proportions297 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (17,234) • 18% Global Research Impact (3,783)
297 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (297)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
DOI: 10.1056/nejmoa1105243 Verified Peer-Reviewed
Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
Published in PLoS ONE•2009
DOI: 10.1371/journal.pone.0005575 Verified Peer-Reviewed
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2033400 Verified Peer-Reviewed
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Published in New England Journal of Medicine•2011
DOI: 10.1056/nejmoa1013607 Verified Peer-Reviewed
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Published in The Lancet Infectious Diseases•2014
DOI: 10.1016/s1473-3099(13)70692-3 Verified Peer-Reviewed
Showing 1 – 5 of 297 publications
1 / 60